Letters HIV

The societal costs of failing to develop a vaccine

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39269.490255.BE (Published 12 July 2007) Cite this as: BMJ 2007;335:60
  1. Jeremiah Norris, director
  1. Center For Science in Public Policy, Hudson Institute, Washington, DC 20005, USA
  1. Jeannie{at}hudson.org

    Policymakers should consider not the cost of developing a vaccine against HIV, but the cost to society if it fails to develop one.1

    In the developed world, some patients on antiretroviral treatment will develop drug resistance and the number will be cumulative each year. Medical care costs will increase exponentially for drug …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe